New Owner
Lundbeck - Synaptic Pharmaceuticals
Lundbeck acquires Synaptic Pharmaceuticals
Announced: November 21, 2002
Type: Acquisition
Disposition: Combined
Status: Complete
Amount: $ 121,000,000